Serpin Pharma LLC

About

Funding history · 2 rounds · $825K total

Q&A

What is Serpin Pharma LLC's primary focus?

Serpin Pharma LLC is a clinical-stage biopharmaceutical company focused on developing first-in-class immune-modulating therapeutics for inflammatory diseases.

What is Serpin Pharma LLC's lead therapeutic candidate?

Serpin Pharma LLC's lead therapeutic, SP16, is a modified peptide derived from alpha-1 antitrypsin (AAT) that aims to restore immune balance by targeting the LRP1 receptor.

For which indications is SP16 undergoing trials?

SP16 is undergoing pre-clinical and clinical trials for various indications, including acute kidney injury (AKI), acute myocardial infarction (AMI), and chemotherapy-induced peripheral neuropathy (CIPN).

When was Serpin Pharma LLC founded?

Serpin Pharma LLC was founded in 2011.

Who is the founder and CEO of Serpin Pharma LLC?

Cohava Gelber is the Founder, Executive Chairperson, and CEO of Serpin Pharma LLC, a position she has held since 2011.

What is the total amount of funding Serpin Pharma LLC has raised?

Serpin Pharma LLC has raised a total of $825,359 through grant funding.

Which organization provided a grant to Serpin Pharma LLC?

Serpin Pharma LLC received a grant of $625,359 from NIH.

What is Serpin Pharma LLC's affiliation with Dogwood Therapeutics?

Dogwood Therapeutics has a global license to develop and commercialize SP16 for intravenous administration in cancer patients.

Who is a recent addition to Serpin Pharma LLC's Board of Directors?

Alexander Fleming was appointed as a Board Member at Serpin Pharma LLC in January 2024.

Team · 9

Cohava Gelber

Founder · Founder, Executive Chairperson, & CEO

Denise Barbut

Board Member

Guy Yachin

Board Member

Alexander Fleming

Board Member

Lawrence Steinman

Scientific Advisory Board Member

Jerome Zeldis

executives

Emanuel Petricoin III

executives

Marc Rothenberg

executives

Halle Raisigel

Director of Corporate Affairs and Operations

Sectors & technology